BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10519416)

  • 1. In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice.
    Abramovitch R; Dafni H; Smouha E; Benjamin LE; Neeman M
    Cancer Res; 1999 Oct; 59(19):5012-6. PubMed ID: 10519416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
    Saleh M; Stacker SA; Wilks AF
    Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin.
    Dafni H; Israely T; Bhujwalla ZM; Benjamin LE; Neeman M
    Cancer Res; 2002 Nov; 62(22):6731-9. PubMed ID: 12438274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
    Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neovasculature induced by vascular endothelial growth factor is fenestrated.
    Roberts WG; Palade GE
    Cancer Res; 1997 Feb; 57(4):765-72. PubMed ID: 9044858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
    Kondo Y; Arii S; Mori A; Furutani M; Chiba T; Imamura M
    Clin Cancer Res; 2000 Feb; 6(2):622-30. PubMed ID: 10690548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
    Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
    Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
    Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of K562 cell growth and tumor angiogenesis in nude mice by antisense VEGF(121) cDNA transfection].
    Ruan G; Liu Y; Chen S; Qin Y; Li J; Fu J; Yu H; Chang Y
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):179-82. PubMed ID: 12133452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
    Zeng G; Gao L; Birklé S; Yu RK
    Cancer Res; 2000 Dec; 60(23):6670-6. PubMed ID: 11118051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.
    Im SA; Gomez-Manzano C; Fueyo J; Liu TJ; Ke LD; Kim JS; Lee HY; Steck PA; Kyritsis AP; Yung WK
    Cancer Res; 1999 Feb; 59(4):895-900. PubMed ID: 10029081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells.
    Ke LD; Shi YX; Yung WK
    Cancer Res; 2002 Mar; 62(6):1854-61. PubMed ID: 11912165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging.
    Abramovitch R; Meir G; Neeman M
    Cancer Res; 1995 May; 55(9):1956-62. PubMed ID: 7537176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
    J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.
    Benjamin LE; Golijanin D; Itin A; Pode D; Keshet E
    J Clin Invest; 1999 Jan; 103(2):159-65. PubMed ID: 9916127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.